Safe and Affordable Drugs from Canada Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 10, 2019)
Safe and Affordable Drugs from Canada Act of 2019
This bill requires the Food and Drug Administration (FDA)to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug
- is dispensed by a pharmacist licensed in Canada;
- is purchased for personal use in quantities not greater than a 90-day supply;
- is filled using a valid prescription issued by a physician licensed to practice in the United States; and
- has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA.
Under the bill, certain drugs may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.
What just happenedJan 25, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 10, 2019
- Jan 25, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 10, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 10, 2019IntroReferralIntro-H
Introduced in House
- Jan 10, 2019IntroReferral1000
Introduced in House